Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by cytochromeon Feb 15, 2024 10:02am
184 Views
Post# 35881677

RE:RE:RE:RE:Something I just seen !

RE:RE:RE:RE:Something I just seen !I am not trying to disparage your comments. Super pulsed has nothing to do with photobiomodulation effects specifically as most research is done with wavelengths in the near infrared 780-1000 nm range. It just so happens Theralase uses super pulsed which is always 904 or 905 nm because of the laser diode properties. Many other non-super pulsed diodes using other wavelengths would also work as the research already indicates. I already pointed out https://symbyxbiome.com/ is approved in Australia for Parkinson's.  FDA approval would be needed becaause it's a class 3 (Canada) 2 (USA) medical device that requires approval to market for the indication. If it was a consumer or wellness device where it's a lower class then yes that is true. TLT is not the world's largest manufacturer of super pulsed laser technology.... Multi radiance in the USA sells significantly more laser devices using 904/905 nm lasers.... I am just trying to ensure accuracy here...
<< Previous
Bullboard Posts
Next >>